According to a CNBC analysis of growth data from eight states by Johns Hopkins University on Friday, Kovid-19 cases are up by 5% or more, based on a weekly average to smooth daily reporting in 11 states by Sunday. was. .
The states were Alaska, Arkansas, Connecticut, Delaware, Maine, Nebraska, New Hampshire, New Jersey, Rhode Island, Wisconsin, and Wyoming. Wisconsin data show that Wisconsin recorded 1,353 new infections at a record high on average of daily new cases, a 32% increase from a week earlier. Both Kansas and Montana achieved record highs for new deaths.
The new data comes two days after Fauci, director of the National Institute of Allergy and Infectious Disease, disagrees with current data on US Kovid-19 outbreaks “disturbing,” President Donald Trump, who said the US outbreak was “round the corner”. . ”
While cases are increasing in 11 states, on an average new cases are decreasing daily in the US. According to a CNBC analysis of Hopkins data, in the past seven days, the country has reported an average of about 34,300 new cases per week, down more than 15% from a week earlier. This is lower than the nearly 70,000 new cases that the US was reporting weeks ago.
Still, 34,300 new cases a day are alarmingly high, infectious disease experts say, and US health officials fear the outbreak may worsen as the nation enters the fall and winter seasons. Health officials have repeatedly warned that they are preparing to fight the two evil viruses roaming later this year as the coronovirus outbreak moves into flu season. Earlier this month, Fauci said the daily new cases were “unacceptably high” which are nearing this fall.
Health officials say the US is unlikely to return to “normal” unless there is a safe and effective vaccine. There are currently no US-approved drugs or vaccines for the virus, although US regulators have authorized certain treatments for emergency use for hospitalized patients.
Earlier in the day, the CEO of Pfizer, the frontrunner of the Covid-19 vaccine, said its vaccine could be distributed to Americans before the end of the year if found safe and effective.
The company is currently under late trial and is expected to enroll 44,000 participants.
Albert Borla told CBS “The Nation” that the drugmaker should have key data for the Food and Drug Administration for its final phase of testing by the end of October. If the FDA approved the vaccine, the company is set to deliver “hundreds of thousands of doses”.
Even if a vaccine is approved to be delivered before the end of the year, it will likely be in short supply. The vaccine will require two doses at different intervals, and states still face logistic challenges such as establishing distribution sites and acquiring needles, syringes, and bottles needed for vaccination.
For now, leaders can prevent new outbreaks by practicing the “basics” of public health and disease control, medical experts and officials.
The World Health Organization suggests that people wear masks to slow the spread of the virus. Scientists say that Kovid-19 can be spread by respiratory droplets that pass when an infected person coughs or sneezes. Studies suggest that masks may serve as a helpful barrier to spreading infection.
The agency advises people to wash their hands regularly, keep distance from others and avoid going to crowded places. If you have fever, cough, and difficulty breathing, seek medical attention, but if possible, call by telephone in advance and follow the instructions of your local health authority.